Drugs and orphan diseases

Therapie. 2020 Apr;75(2):131-132. doi: 10.1016/j.therap.2020.02.002. Epub 2020 Feb 13.

Authors

Olivier Blin¹, Joelle Micallef²

Affiliations

¹ Service de pharmacologie clinique et pharmacovigilance, Aix-Marseille université, UMR INSERM 1106 Inst Neurosc Syst, AP-HM, OrphanDev, Marseille, France. Electronic address: olivier.blin@ap-hm.fr.
² Service de pharmacologie clinique et pharmacovigilance, Aix-Marseille université, UMR INSERM 1106 Inst Neurosc Syst, AP-HM, OrphanDev, Marseille, France. Electronic address: joelle.micallef@ap-hm.fr.

PMID: 32247679
DOI: 10.1016/j.therap.2020.02.002

No abstract available

Publication types

Editorial

MeSH terms

Drug Approval
Humans
Orphan Drug Production
Pharmaceutical Preparations*
Rare Diseases* / drug therapy

Substances

Pharmaceutical Preparations